{"id":"W2582502952","doi":"10.1182/blood.v104.11.2479.2479","title":"Targeting FGFR3 in t(4;14) Mutiple Myeloma: Pre-Clinical Studies of PRO-001, a Novel Anti-FGFR3 Neutralizing Antibody.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chromosomal translocation; Cancer research; Biology; Antibody; Multiple myeloma; Molecular biology; Fibroblast growth factor receptor 3; Cyclin D1; Phage display; Receptor tyrosine kinase; Receptor; Cancer; Fibroblast growth factor; Gene; Genetics; Immunology; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008439446,0.0005743993,0.000407511,0.0002461183,0.0002115327,0.0004867952,0.0005218596,0.000534423,0.001227237],"category_scores_gemma":[0.0003359519,0.0001818122,0.0003700453,0.0001434082,0.0003383158,0.0003229487,0.0001840034,0.001302397,0.0004262932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005724254,"about_ca_system_score_gemma":0.000592099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001228478,"about_ca_topic_score_gemma":0.002061076,"domain_scores_codex":[0.9998088,0.00005561674,0.000008619312,0.00002171904,0.00003513653,0.00007004048],"domain_scores_gemma":[0.999821,0.00004061877,0.00002826527,0.000009998308,0.00002380942,0.00007637011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01662287,0.03579318,0.005999068,0.000490476,0.0003266945,0.0007990146,0.000419003,0.003003462,0.8191506,0.000717321,0.00298943,0.1136889],"study_design_scores_gemma":[0.01362489,0.4993761,0.04690753,0.00006390608,0.0006033243,0.003618796,0.0002524381,0.005147103,0.4002541,0.0005184939,0.02956893,0.00006425833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926841,0.002890335,0.0008664017,0.0003652235,0.00004726961,0.0003224625,0.0002954334,0.00005875021,0.002470165],"genre_scores_gemma":[0.9953676,0.001415474,0.0006163093,0.0002358452,0.0000244753,0.0001198565,0.0006469216,0.00001177696,0.001561773],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001228478,"threshold_uncertainty_score":0.004463255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0834791114309878,"score_gpt":0.4136889756930822,"score_spread":0.3302098642620944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}